Published in Support Care Cancer on September 01, 2004
Clinical potential of naloxegol in the management of opioid-induced bowel dysfunction. Clin Exp Gastroenterol (2014) 0.97
Opioid analgesics and P-glycoprotein efflux transporters: a potential systems-level contribution to analgesic tolerance. Curr Top Med Chem (2011) 0.96
Constipation in people prescribed opioids. BMJ Clin Evid (2010) 0.88
Quality of life and healthcare resource in patients receiving opioids for chronic pain: a review of the place of oxycodone/naloxone. Clin Drug Investig (2015) 0.88
Opioids and efflux transporters. Part 2: P-glycoprotein substrate activity of 3- and 6-substituted morphine analogs. J Med Chem (2008) 0.87
Cancer constipation: are opioids really the culprit? Support Care Cancer (2008) 0.86
[Opioid-induced bowel dysfunction: a literature analysis on pathophysiology and treatment]. Wien Med Wochenschr (2008) 0.76
The Impact of Opioid Treatment on Regional Gastrointestinal Transit. J Neurogastroenterol Motil (2016) 0.76
Symptom-related emergency department visits and hospital admissions during ambulatory cancer treatment. J Community Support Oncol (2015) 0.75
Developments in managing severe chronic pain: role of oxycodone-naloxone extended release. Drug Des Devel Ther (2015) 0.75
Opioid and chronic non-cancer pain. J Anaesthesiol Clin Pharmacol (2013) 0.75
Constipation in Elderly Patients with Noncancer Pain: Focus on Opioid-Induced Constipation. Drugs Aging (2016) 0.75
Genetic and Non-genetic Factors Associated With Constipation in Cancer Patients Receiving Opioids. Clin Transl Gastroenterol (2015) 0.75
Chronic constipation. N Engl J Med (2003) 4.58
Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies. N Engl J Med (1990) 2.67
Incidence, prevalence, and management of opioid bowel dysfunction. Am J Surg (2001) 2.63
Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol (2001) 2.25
Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation. Aliment Pharmacol Ther (2001) 2.04
Metoclopramide. An updated review of its pharmacological properties and clinical use. Drugs (1983) 2.02
AGA technical review on constipation. American Gastroenterological Association. Gastroenterology (2000) 1.87
Opioid-induced delay in gastric emptying: a peripheral mechanism in humans. Anesthesiology (1997) 1.87
Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. J Pain (2003) 1.85
Insights into opioid action in the intestinal tract. Pharmacol Ther (1996) 1.61
Opioid rotation for cancer pain: rationale and clinical aspects. Cancer (1999) 1.54
The treatment of chronic constipation in adults. A systematic review. J Gen Intern Med (1997) 1.49
Constipation in advanced cancer patients. Support Care Cancer (1998) 1.36
Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders. Circulation (2000) 1.33
Role of opiate receptors in the regulation of colonic transit. Gastroenterology (1988) 1.21
Oral naloxone reverses opioid-associated constipation. Pain (2000) 1.20
Alvimopan* (ADL 8-2698) is a novel peripheral opioid antagonist. Am J Surg (2001) 1.20
Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial. Clin Pharmacol Ther (1996) 1.17
Effect of wheat bran on weight of stool and gastrointestinal transit time: a meta analysis. Br Med J (Clin Res Ed) (1988) 1.17
Inhibition of gastrointestinal transit by morphine in rats results primarily from direct drug action on gut opioid sites. J Pharmacol Exp Ther (1986) 1.15
The central and peripheral influences of opioids on gastrointestinal propulsion. Annu Rev Pharmacol Toxicol (1985) 1.11
Effects of metoclopramide and bethanechol on delayed gastric emptying present in gastroesophageal reflux patients. Gastroenterology (1983) 1.10
An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer. Palliat Med (1996) 1.07
Constipation and the use of laxatives: a comparison between transdermal fentanyl and oral morphine. Palliat Med (2000) 1.06
The plain abdominal radiograph in the assessment of constipation. Z Gastroenterol (1990) 1.03
Peptide opioid antagonist separates peripheral and central opioid antitransit effects. J Pharmacol Exp Ther (1987) 0.98
A review of the potential role of methylnaltrexone in opioid bowel dysfunction. Am J Surg (2001) 0.98
Decreased substance P levels in rectal biopsies from patients with slow transit constipation. Eur J Gastroenterol Hepatol (1996) 0.98
ABC of palliative care. Constipation and diarrhoea. BMJ (1997) 0.94
Prevention of opioid side effects. J Pain Symptom Manage (1990) 0.93
Treatment of chronic constipation with cisapride and placebo. Gut (1987) 0.93
Surgical management of intestinal obstruction in ovarian cancer. I. Clinical features, postoperative complications, and survival. Gynecol Oncol (1987) 0.92
Treatment of opioid-induced constipation with oral naloxone: a pilot study. Clin Pharmacol Ther (1992) 0.92
Reduction in constipation and laxative requirements following opioid rotation to methadone: a report of four cases. J Pain Symptom Manage (1999) 0.89
Morphine, constipation and performance status in advanced cancer patients. Palliat Med (1999) 0.89
Efficacy of senna versus lactulose in terminal cancer patients treated with opioids. J Pain Symptom Manage (1998) 0.88
Oral naloxone antagonizes loperamide-induced delay of orocecal transit. Dig Dis Sci (1987) 0.88
Treatment of chronic constipation with colchicine: randomized, double-blind, placebo-controlled, crossover trial. Am J Gastroenterol (2003) 0.87
The analgesic tramadol has minimal effect on gastrointestinal motor function. Br J Clin Pharmacol (1997) 0.84
Diffuse mesenteric amyloidosis. Dig Dis Sci (1997) 0.82
Side effects of morphine administration in cancer patients. Cancer Nurs (1998) 0.82
A volunteer model for the comparison of laxatives in opioid-related constipation. J Pain Symptom Manage (1996) 0.80
Comparison of the effect of cisapride and metoclopramide on morphine-induced delay in gastric emptying. Br J Clin Pharmacol (1988) 0.80
The assessment of constipation in terminal cancer patients admitted to a palliative care unit: a retrospective review. J Pain Symptom Manage (1994) 0.80
Constipation. Med Clin North Am (2000) 0.79
Management of common opioid side effects during long-term therapy of cancer pain. Ann Acad Med Singapore (1994) 0.78
Continuous Sc infusion of metoclopramide for treatment of narcotic bowel syndrome. Cancer Treat Rep (1987) 0.76
MICROENEMA AS EVACUANT BEFORE PROCTOSCOPY. Curr Ther Res Clin Exp (1965) 0.75